Survival Outcomes Following Combination of First-Line Platinum-Based Chemotherapy with S-1 in Patients with Advanced Gastric Cancer

SIMPLE SUMMARY: Regardless of recent advances in the understanding of cancer biology, gastric cancer remains one of the leading causes of death worldwide. The efficacy of tegafur/gimeracil/oteracil (S-1) combined with a platinum agent in the first-line setting in advanced gastric cancer has been pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Koumarianou, Anna, Ntavatzikos, Anastasios, Vallilas, Christos, Kampoli, Katerina, Kakoseou, Zoi, Karamouzis, Michalis V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765389/
https://www.ncbi.nlm.nih.gov/pubmed/33333977
http://dx.doi.org/10.3390/cancers12123780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765389/
https://www.ncbi.nlm.nih.gov/pubmed/33333977
http://dx.doi.org/10.3390/cancers12123780

Ejemplares similares